Soros Fund Management LLC Takes Position in UnitedHealth Group Incorporated (NYSE:UNH)

Soros Fund Management LLC acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, HoldingsChannel reports. The institutional investor acquired 77,913 shares of the healthcare conglomerate’s stock, valued at approximately $39,413,000.

Several other institutional investors also recently bought and sold shares of UNH. Sugarloaf Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 17.6% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after buying an additional 1,193 shares during the period. Signal Advisors Wealth LLC raised its position in shares of UnitedHealth Group by 13.0% in the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock worth $4,611,000 after acquiring an additional 1,051 shares during the period. Waycross Partners LLC raised its position in shares of UnitedHealth Group by 2.4% during the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock worth $14,060,000 after purchasing an additional 658 shares during the last quarter. Czech National Bank grew its stake in UnitedHealth Group by 6.1% during the 4th quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate’s stock valued at $100,937,000 after acquiring an additional 11,426 shares in the last quarter. Finally, Lmcg Investments LLC grew its stake in UnitedHealth Group by 11.8% during the 4th quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate’s stock valued at $19,210,000 after acquiring an additional 4,022 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 0.3 %

Shares of UNH opened at $420.04 on Tuesday. UnitedHealth Group Incorporated has a 52 week low of $412.02 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market capitalization of $382.33 billion, a price-to-earnings ratio of 27.10, a PEG ratio of 1.37 and a beta of 0.61. The business’s fifty day moving average price is $501.46 and its two-hundred day moving average price is $532.94.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter last year, the firm earned $6.91 EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.00%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 35.18%.

Analysts Set New Price Targets

UNH has been the subject of several analyst reports. Hsbc Global Res cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 22nd. KeyCorp lowered their price objective on UnitedHealth Group from $650.00 to $575.00 and set an “overweight” rating for the company in a research report on Monday, April 21st. HSBC reissued a “hold” rating and issued a $490.00 target price on shares of UnitedHealth Group in a report on Tuesday, April 22nd. Piper Sandler reduced their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Finally, Wells Fargo & Company cut their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $603.05.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.